4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal VaccinationBacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, pneumococcal infection, pneumonia, respiratory system disorder, respiratory tract infectious disorder, streptococcal infectionActive, not recruitingPhase 32026-06-30NCT07425392
Adaptation and Evaluation of Bright HorizonsChemically-Induced Disorders, Substance Use, alcohol abuse, alcohol-related disorders, psychiatric disorder, substance-related disorderRecruitingNot applicable2026-06-09NCT05743699
Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, lung disorder, pneumococcal infection, pneumonia, respiratory system disorder, respiratory tract infectious disorder, streptococcal infectionActive, not recruitingPhase 32026-05-15NCT07284654
Native-RISE (Risk Identification for Suicide and Enhanced Care)Suicide PreventionEnrolling by invitationNot applicable2026-02-02NCT06782516